Combination chemotherapy in cancer: principles, evaluation and drug delivery strategies AC Pinto, JN Moreira, S Simões Current Cancer Treatment-Novel Beyond Conventional Approaches, 2011 | 85 | 2011 |
Artificial neural networks applied to quality-by-design: From formulation development to clinical outcome MF Simões, G Silva, AC Pinto, M Fonseca, NE Silva, RMA Pinto, ... European Journal of Pharmaceutics and Biopharmaceutics 152, 282-295, 2020 | 63 | 2020 |
Liposomal imatinib–mitoxantrone combination: Formulation development and therapeutic evaluation in an animal model of prostate cancer AC Pinto, JN Moreira, S Simões The Prostate 71 (1), 81-90, 2011 | 45 | 2011 |
Ciprofloxacin sensitizes hormone-refractory prostate cancer cell lines to doxorubicin and docetaxel treatment on a schedule-dependent manner AC Pinto, JN Moreira, S Simões Cancer chemotherapy and Pharmacology 64, 445-454, 2009 | 35 | 2009 |
Schedule treatment design and quantitative in vitro evaluation of chemotherapeutic combinations for metastatic prostate cancer therapy AC Pinto, S Ângelo, JN Moreira, S Simões Cancer chemotherapy and pharmacology 67, 275-284, 2011 | 25 | 2011 |
Oromucosal products–Market landscape and innovative technologies: A review F Bastos, AC Pinto, A Nunes, S Simoes Journal of Controlled Release 348, 305-320, 2022 | 13 | 2022 |
Development, characterization and in vitro evaluation of single or co-loaded imatinib mesylate liposomal formulations AC Pinto, S Angelo, JN Moreira, S Simoes Journal of nanoscience and nanotechnology 12 (3), 2891-2900, 2012 | 7 | 2012 |
Quimioterapia combinada no tratamento do cancro: princípios e estratégias nanotecnológicas de entrega de fármacos AC Pinto, JN Moreira, S Simões Imprensa da Universidade de Coimbra, 2015 | | 2015 |
Development of liposomal chemotherapeutic formulations for prostate cancer therapy: combination of conventional chemotherapy and a novel generation of anticancer drugs ACS Pinto Development of liposomal chemotherapeutic formulations for prostate cancer …, 2010 | | 2010 |
In vitro evaluation of combined effects of conventional and new cytotoxic agents against a hormone-refractory prostate cancer (HRPC) cell line AC Pinto, JN Moreira, S Simoes BJU INTERNATIONAL 100, 35-36, 2007 | | 2007 |